Bumrungrad Hospital (BH) Q3 2026 Pre recorded earnings summary

Executive summary

• Q3 2026 consolidated revenue and profit increased YoY; nine-month revenue, operating profit and net profit also exceeded 2025 levels.

• Interim financial information received an auditor review conclusion with no material exceptions identified under Thai Accounting Standard 34.

Financial highlights

• Q3 consolidated revenue was THB 6,726,511 thousand vs THB 6,581,502 thousand; operating profit was THB 2,509,222 thousand vs THB 2,461,675 thousand.

• Q3 consolidated net profit was THB 2,078,062 thousand vs THB 2,046,719 thousand; profit attributable to equity holders was THB 2,064,862 thousand vs THB 2,034,954 thousand.

• 9M consolidated revenue was THB 19,253,116 thousand vs THB 18,890,293 thousand; operating profit was THB 6,990,229 thousand vs THB 6,822,775 thousand.

• 9M consolidated net profit was THB 5,788,378 thousand vs THB 5,670,115 thousand; profit attributable to equity holders was THB 5,744,051 thousand vs THB 5,626,417 thousand.

Key financial ratios and metrics

• Q3 basic/diluted EPS was Baht 2.60/Baht 2.38 vs Baht 2.56/Baht 2.35; 9M basic/diluted EPS was Baht 7.23/Baht 6.62 vs Baht 7.08/Baht 6.49.

• 9M net cash from operating activities was THB 6,978,178 thousand vs THB 6,156,444 thousand; period-end cash and cash equivalents were THB 5,422,054 thousand vs THB 7,595,105 thousand at year-end 2025.